Susan Boynton is Vice President, Global Regulatory Affairs at Shire Human Genetic Therapies based in Lexington, MA. Susan has over 25 years of experience in global regulatory affairs spanning multiple therapeutic areas in drug development for both small and large molecules. Susan’s career has focused on global regulatory drug development in areas of unmet medical need particularly rare diseases and orphan drugs. Prior to her current position Susan was Executive Director, Global Regulatory Affairs at Amgen and has worked in a number of senior regulatory positions across multiple continents including Abbott Laboratories, Sanofi, Organon and Novartis. Susan has also been an active member of various industry organizations including PhRMA and BIO. Susan obtained her BS degree with Honors in Pharmacology from the University of Sunderland, UK and obtained her post graduate diploma in Law from the College of Law, England and Wales. Susan also graduated from Loyola University, School of Law, Chicago with a Masters Degree in Jurisprudence, Health Law specializing in US Food & Drug Law and Bioethics.